Fluorometholone

Generic name
Fluorometholone
Brand name
ATC Code
S01BA07

Fluorometholone

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Inflammatory, non-infectious conditions of the conjunctiva, uveitis and post-operative
  • Ocular
    • < 2 years
      • 1 drop(s)/dose 1-4x daily.
      • No studies have been carried out into the use of fluorometholone in children aged under 2 years

    • 2 years up to 18 years
      • 1 - 2 drop(s)/dose 2-4x daily.
      • If necessary during the first 24-48 hours: 2 drops at intervals of 1 hour

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Application of corticosteroids to the eye should be done under the supervision of an ophthalmologist.
 

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIINFLAMMATORY AGENTS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Corticosteroids, plain
S01BA01
S01BA04
S01BA13

References

  1. Rademaker CAM et al, Geneesmiddelen Formularium voor Kinderen, UMCU/WKZ , 2008
  2. Allergan Pharmaceuticals Ireland, SPC FML Liquifilm (RVG 06539), www.cbg-meb.nl, Geraadpleegd 27okt2011, http://db.cbg-meb.nl/IB-teksten/h06539.pdf
  3. Rademaker CAM et al, Geneesmiddelen Formularium voor Kinderen, UMCU/WKZ, 2008

Changes

Therapeutic Drug Monitoring


Overdose